Skip to content
TXG 10x Genomics, Inc. Class A Common Stock
$7.92 2.86% +0.22
Notify me if price changes either direction
Interactive Brokers Logotype

Buy TXG stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 924.7M
Enterprise value 628.5M
Trailing PE -5.2072368421053
Forward PE -6.2950816
PEG Ratio -6.2950816
Enterprise to EBITDA -4.014
Enterprise to revenue 1.029
Price to book MRQ 1.3225417
Price to sales TTM 1.514008

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2024-12-31
Revenue (TTM) 610.8M
EBITDA -156580000
Diluted EPS TTM -1.52
Total Cash (MRQ) 393.4M
Current ratio (MRQ) 4.968
Operating Cash Flow (TTM) 6.7M

TXG trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent TXG News

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.